Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
about
Olive Oil and the Hallmarks of AgingThe role of melatonin in diabetes: therapeutic implicationsThe Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment.Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.New targets for rapid antidepressant action.Melatonin and female hormone secretion in postmenopausal overweight womenThe effect of melatonin supplementation on the quality of sleep and weight status in postmenopausal womenAssessment of cardiometabolic risk among shift workers in Hungary.Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceMelatonin Therapy in Patients with Alzheimer's Disease.Therapeutic application of melatonin in mild cognitive impairment.Melatonin may curtail the metabolic syndrome: studies on initial and fully established fructose-induced metabolic syndrome in ratsMelatonin improves sleep quality in hemodialysis patients.Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression.Mitochondrial DNA and inflammatory diseases.Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors.Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Cardiovascular effects of melatonin receptor agonists.Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms.Current Phase II investigational therapies for insomnia.Inter-relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity.Melatonin, mitochondria, and the metabolic syndrome.Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder.Chronomedicine and type 2 diabetes: shining some light on melatonin.Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?Pinealectomy interferes with the circadian clock genes expression in white adipose tissue.Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats.CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake.Insulin resistance: a risk marker for disease and disability in the older person.Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats.Alterations in Metabolism and Diurnal Rhythms following Bilateral Surgical Removal of the Superior Cervical Ganglia in Rats.Early-life sleep deprivation persistently depresses melatonin production and bio-energetics of the pineal gland: potential implications for the development of metabolic deficiency.Melatonin attenuates smoking-induced hyperglycemia via preserving insulin secretion and hepatic glycogen synthesis in rats.Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial.Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle.Discontinuous versus continuous drinking of ethanol in peripubertal rats: effect on 24-hour pattern of hypophyseal-gonadal axis activity and anterior pituitary oxidative stress.A circadian rhythm-related MTNR1B genetic variant modulates the effect of weight-loss diets on changes in adiposity and body composition: the POUNDS Lost trial.Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)
P2860
Q26769864-13F001CE-91EF-4E98-9C8E-B4654BC4935DQ26786629-BB804B1B-16CC-4E68-AA62-712EBE82DDA8Q33786661-35F14D82-9409-4A18-93BD-0BF0C8A3D6D0Q34358480-2FA100A0-2D9B-415F-A1DA-622CD8045B02Q34507177-F323B11F-57BF-453D-89B9-6A366D48ADE6Q35016542-FCF11C8E-6D4F-4C18-B177-404898BEA030Q35157312-908FD6A6-FE1E-4277-A990-BE58F9571C11Q35808919-8F5A8EE6-E946-4A36-8B72-CC24286971B2Q36040915-F3A5592F-00D0-4FA2-A6C5-534BBB4EEC2DQ36067334-6FB8E740-6CC0-4C42-8B18-EC444290FC58Q36335048-B49783E2-034F-4C1A-87E1-9FE55BE30FCBQ36576496-ADF57C77-75DA-4AC6-81C3-8656698E668AQ36655972-CF9CA3CA-BDDC-497A-8939-45BD657FD188Q37091140-C1070299-F301-4D64-94EE-FA7694515A78Q37888682-9627B508-22B6-4FFA-8D23-CAB24FBAF49AQ37898562-86A3D18E-28C9-4215-831A-D77823549A12Q37945726-2040C805-762D-4E99-BF88-E6715E1AABE7Q37973897-76812E07-DF2B-4E9B-B83F-6F9FD41BBD3FQ38022179-CD489444-625E-4C0B-9AE7-0156086044D4Q38037124-BF01CD33-4482-4559-8F69-B337D2A13447Q38151200-5C0FD5BB-1D31-46BB-9969-D28ECC076E17Q38271292-21642BF2-B445-4BEE-A27F-C4E0E44590F4Q38535532-E048A8F6-8C7C-4A1A-B990-E45E7A2C80CAQ38618827-7CA65D22-D0ED-483B-9FF9-1F02B396F467Q38803216-5BA08ED8-04F8-41E1-ACB1-DB433180C0DCQ39040818-72EFEA0E-A52C-48DA-988C-C377D461D25BQ41441546-9FB2DF37-AAC9-4758-A2AF-FFCCB80CF6C2Q41519308-65B22E41-9FDC-4CCD-AD25-DDE681535EA0Q42513420-622F4453-DBD9-422C-B5AD-758E5BBE8BFDQ44956801-B0DA0BC8-CFB5-4B6B-8C6A-566436D8E47BQ45330314-AC3C9FC1-C58B-4C48-A40C-F49C431094F2Q46577413-4FDCAC2A-6982-4B0E-9B87-0CCFBAA53F21Q47835885-AD4D6D2E-9D2C-45E7-99EC-D79412B4F72BQ48126344-FF6F4973-E09C-4E2E-A6E8-829F2F2593E9Q50044791-C924A211-A60C-4B41-B786-17F9968E3399Q50654258-A8FB7D88-6CE2-4058-A9DC-C2AC6E05E971Q51713401-CFB28AFC-83DD-4032-9CA1-D2DA5BE63949Q52621075-D3CF7CC2-2959-4553-BED6-5C85BCA5002DQ52667791-74630944-42E1-44BA-B0AB-2D0A5A9DF043Q58798803-59D94FFF-422C-4AF7-A918-C73CB9C6C19E
P2860
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
@en
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
@nl
type
label
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
@en
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
@nl
prefLabel
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
@en
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
@nl
P2093
P356
P1433
P1476
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.
@en
P2093
Ana I Esquifino
Daniel P Cardinali
Pilar Cano
Vanesa Jiménez-Ortega
P304
P356
10.1159/000324699
P577
2011-02-25T00:00:00Z